Wallace Advisory Group LLC Sells 27 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wallace Advisory Group LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the third quarter, Holdings Channel reports. The fund owned 2,761 shares of the healthcare conglomerate’s stock after selling 27 shares during the quarter. UnitedHealth Group comprises approximately 1.1% of Wallace Advisory Group LLC’s investment portfolio, making the stock its 19th biggest holding. Wallace Advisory Group LLC’s holdings in UnitedHealth Group were worth $1,614,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of UNH. Bell Investment Advisors Inc lifted its stake in shares of UnitedHealth Group by 4.8% in the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after buying an additional 24 shares during the period. Harbor Investment Advisory LLC lifted its stake in shares of UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after buying an additional 1,129 shares during the period. Austin Private Wealth LLC lifted its stake in shares of UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after buying an additional 111 shares during the period. Capital Insight Partners LLC lifted its stake in shares of UnitedHealth Group by 3.8% in the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after buying an additional 332 shares during the period. Finally, Collective Family Office LLC raised its position in UnitedHealth Group by 4.3% in the first quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock worth $780,000 after purchasing an additional 65 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.3 %

UNH traded down $1.55 during trading on Friday, hitting $591.20. The company had a trading volume of 2,463,201 shares, compared to its average volume of 3,965,528. The company has a market capitalization of $544.13 billion, a PE ratio of 36.14, a PEG ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The firm’s 50-day moving average price is $582.24 and its 200 day moving average price is $527.36. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the previous year, the firm posted $6.14 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research firms recently issued reports on UNH. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price target for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Truist Financial increased their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. HSBC raised their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Barclays raised their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Finally, Morgan Stanley raised their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.